12 Health Care Stocks Moving In Thursday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Thursday's after-market session, several health care stocks showed significant movement. Ontrak, Ocuphire Pharma, and Lyell Immunopharma were among the top gainers, with Ontrak leading at an 18.7% increase. Conversely, Motus GI Holdings, Acorda Therapeutics, and Nurix Therapeutics were the top losers, with Motus GI Holdings experiencing a 32.6% decline. Notably, Nurix Therapeutics' drop was following their Q1 earnings report.
April 11, 2024 | 8:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Motus GI Holdings faced a sharp 32.6% decline, marking it as one of the session's biggest losers.
The drastic drop in Motus GI Holdings' stock price could reflect investor reactions to company-specific news or negative market trends.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Nurix Therapeutics' shares fell 9.36% following their Q1 earnings report, indicating a negative market reaction.
The decline in Nurix Therapeutics' stock price post-earnings suggests that the market reacted negatively to their Q1 financial performance.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 95
POSITIVE IMPACT
Ontrak shares surged 18.7% in after-market trading, indicating strong investor interest.
The significant increase in Ontrak's stock price suggests positive investor sentiment, potentially due to company-specific news or broader market trends.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90